Comprasion of nifedipin versus magnesium salfate in Treatment of preterm labor

Phase 3

Conditions: preterm labor.
Preterm labour and delivery

Registration Number: IRCT201301281760N20

Lead Sponsor: Vice Chancellor for Research and Technology, Babol University of Medical Sciences

Brief Summary: Not available

Detailed Description: Not available

Recruitment & Eligibility

Status: Complete

Sex: Female

Target Recruitment: 120

Inclusion Criteria

24w-34w gestational age with a diagnosis of preterm labor; at least four contractions[During the 30 in 20 minutes with increasing cervical dilatation and effacement] (2cm dilatation or effacement of 80%).
Exclusion criteria: multiple pregnancies; corioamnionitis? preeclampsia, abruption previa, liver disease, heart and blood pressure, maternal vaginal bleeding; IUGR; IUFD; Fetal distress, fetal major anomaly; PPROM; (PR> 100, BP <90/50) ³ 5cm dilatation.

Exclusion Criteria

Not provided

Study & Design

Study Type: interventional

Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Premature birth control. Timepoint: Before 37 weeks of gestation. Method of measurement: Clinical.

Secondary Outcome Measures

Name	Time	Method
Adverse effects of maternal magnesium sulfate versus nifedipine. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: clinical.;Magnesium sulfate versus nifedipine complication rate of fetal tachycardia. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: clinical.;The effect of nifedipine versus magnesium sulfate to stop the contractions of. Timepoint: Three days a week during the first 48 hours of onset of pain. Method of measurement: Clinical.